These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 8799498

  • 21. Pharmacokinetic profile of glycyrrhizin in healthy volunteers by a new high-performance liquid chromatographic method.
    Yamamura Y, Kawakami J, Santa T, Kotaki H, Uchino K, Sawada Y, Tanaka N, Iga T.
    J Pharm Sci; 1992 Oct; 81(10):1042-6. PubMed ID: 1432618
    [Abstract] [Full Text] [Related]

  • 22. Prediction of glycyrrhizin disposition in rat and man with liver failure by a physiologically based pharmacokinetic model.
    Ishida S, Sakiya Y, Ichikawa T, Taira Z, Awazu S.
    J Pharmacobiodyn; 1990 Feb; 13(2):142-57. PubMed ID: 2384851
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Comparative pharmacokinetic behavior of glycyrrhetic acid after oral administration of glycyrrhizic acid and Gancao-Fuzi-Tang.
    Gao QT, Chen XH, Bi KS.
    Biol Pharm Bull; 2004 Feb; 27(2):226-8. PubMed ID: 14758039
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Bioavailability of glycyrrhizin and licorice extract in rat and human plasma as detected by a HPLC method.
    Raggi MA, Maffei F, Bugamelli F, Cantelli Forti G.
    Pharmazie; 1994 Apr; 49(4):269-72. PubMed ID: 8197226
    [Abstract] [Full Text] [Related]

  • 30. Pharmacokinetic profiles of glycyrrhizin in patients with chronic hepatitis.
    Tanaka N, Yamamura Y, Santa T, Kotaki H, Uchino K, Sawada Y, Aikawa T, Osuga T, Iga T.
    Biopharm Drug Dispos; 1993 Oct; 14(7):609-14. PubMed ID: 8251615
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Preparation and rectal absorption of highly concentrated glycyrrhizin solution.
    Koga K, Kawashima S, Shibata N, Takada K, Murakami M.
    Biol Pharm Bull; 2003 Sep; 26(9):1299-305. PubMed ID: 12951475
    [Abstract] [Full Text] [Related]

  • 33. Therapeutic basis of glycyrrhizin on chronic hepatitis B.
    Sato H, Goto W, Yamamura J, Kurokawa M, Kageyama S, Takahara T, Watanabe A, Shiraki K.
    Antiviral Res; 1996 May; 30(2-3):171-7. PubMed ID: 8783808
    [Abstract] [Full Text] [Related]

  • 34. Enhanced distribution and extended elimination of glycyrrhetinic acid in mice liver by mPEG-PLA modified (mPEGylated) liposome.
    Li J, Yu H, Li S, Wang GJ.
    J Pharm Biomed Anal; 2010 Apr 06; 51(5):1147-53. PubMed ID: 20005656
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Hydrolysis of glycyrrhizin to 18 beta-glycyrrhetyl monoglucuronide by lysosomal beta-D-glucuronidase of animal livers.
    Akao T, Akao T, Hattori M, Kanaoka M, Yamamoto K, Namba T, Kobashi K.
    Biochem Pharmacol; 2010 Apr 06; 41(6-7):1025-9. PubMed ID: 2009072
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.